S.Africa seals record deal for low-cost ARVs: minister

South Africa, home to the world's largest population of people living with HIV, said Thursday it had secured a deal to buy a key anti-retroviral (ARV) drug at the lowest price ever.

The country is the world's largest consumer of the life-saving drugs, at 21 percent of the world market.

Aaron Motsoaledi announced the country had used this massive market share to negotiate a record-low price on a three-in-one, fixed-dose .

The once-a-day tablet will cost patients 89.37 rand a month ($10, eight euros), the minister said.

"This is now the world's lowest price for this product," he said.

"In pursuit of and using innovative methods we have been able to (achieve) a massive saving."

Motsoaledi said the government had awarded a two-year, 5.9-billion-rand ($671-million, 517-million-euro) tender to three for the drug, down from an original cost of 8.1 billion rand.

Aspen Pharmacare, Cipla Medpro and Mylan pharmaceuticals are the three companies that won the tender.

The government plans to expand the treatment to reach 2.5 million people in the next two years. Patients have been taking three pills a day, but the new regimen reduces them to one and the combination has fewer side effects.

South Africa once refused to roll out ARVs under former president Thabo Mbeki, whom activists have condemned as an "AIDS denialist". But the country now has the largest anti-retroviral (ARV) programme in the world, serving 1.7 million of its 5.6 million HIV-positive people.

Demographers reported recently that life expectancy in South Africa had shot up by six years to 60 over the past few years thanks to ARV treatment.

The country has one of the world's highest , at 17.8 percent of 15- to 49-year-olds.

Doctors Without Borders (MSF) praised the deal, saying the government had used its negotiating power to buy the fixed-dose combinations at "extremely competitive prices".

Patients "now finally have access to simpler and improved treatment options—which significantly cuts down their daily pill burden from three to five pills down to just one," said Gilles Van Cutsem, the aid group's medical coordinator in South Africa.

add to favorites email to friend print save as pdf

Related Stories

S. African to double HIV patient treatment

Dec 14, 2010

(AP) -- South Africa's health minister says he has brought down the cost of HIV drugs by 53 percent, enabling the government to treat twice as many patients in the next two years.

South Africa unveils plan to halve HIV infections

Dec 01, 2011

President Jacob Zuma on Thursday unveiled a plan to halve the number of HIV infections over the next five years, cementing South Africa's turnaround from years of deadly denialism.

Recommended for you

The genetics of coping with HIV

Sep 16, 2014

We respond to infections in two fundamental ways. One, which has been the subject of intensive research over the years, is "resistance," where the body attacks the invading pathogen and reduces its numbers. Another, which ...

Long acting HIV drugs to be developed

Sep 11, 2014

HIV drugs which only need to be taken once a month are to be developed at the University of Liverpool in a bid to overcome the problem of 'pill fatigue'.

Puerto Rico partners on US HIV vaccine project

Sep 10, 2014

Puerto Rico's governor says the island's largest public university is partnering with federal agencies to oversee a U.S.-funded project aimed at trying to develop a prophylactic vaccine for the HIV virus that causes AIDS.

User comments